These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2744854)

  • 1. Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis.
    Ramsey KH; Newhall WJ; Rank RG
    Infect Immun; 1989 Aug; 57(8):2441-6. PubMed ID: 2744854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Vaccine; 1997 Apr; 15(5):575-82. PubMed ID: 9160528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
    Ramsey KH; Cotter TW; Salyer RD; Miranpuri GS; Yanez MA; Poulsen CE; DeWolfe JL; Byrne GI
    Infect Immun; 1999 Jun; 67(6):3019-25. PubMed ID: 10338514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa.
    Hawkins RA; Rank RG; Kelly KA
    Infect Immun; 2002 Sep; 70(9):5132-9. PubMed ID: 12183563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
    Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
    Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the humoral immune response to chlamydial genital infection in guinea pigs.
    Batteiger BE; Rank RG
    Infect Immun; 1987 Aug; 55(8):1767-73. PubMed ID: 3610314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response in mice infected in the genital tract with mouse pneumonitis agent (Chlamydia trachomatis biovar).
    Barron AL; Rank RG; Moses EB
    Infect Immun; 1984 Apr; 44(1):82-5. PubMed ID: 6706408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
    Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
    Cotter TW; Meng Q; Shen ZL; Zhang YX; Su H; Caldwell HD
    Infect Immun; 1995 Dec; 63(12):4704-14. PubMed ID: 7591126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.
    Igietseme JU; Uriri IM; Kumar SN; Ananaba GA; Ojior OO; Momodu IA; Candal DH; Black CM
    Infect Immun; 1998 Sep; 66(9):4030-5. PubMed ID: 9712743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.
    Pal S; Fielder TJ; Peterson EM; de la Maza LM
    Infect Immun; 1994 Aug; 62(8):3354-62. PubMed ID: 8039906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis.
    Cain TK; Rank RG
    Infect Immun; 1995 May; 63(5):1784-9. PubMed ID: 7729886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis.
    Williams DM; Grubbs BG; Pack E; Kelly K; Rank RG
    Infect Immun; 1997 Jul; 65(7):2876-82. PubMed ID: 9199462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection.
    Ramsey KH; Soderberg LS; Rank RG
    Infect Immun; 1988 May; 56(5):1320-5. PubMed ID: 3258586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic chlamydial genital infection in congenitally athymic nude mice.
    Rank RG; Soderberg LS; Barron AL
    Infect Immun; 1985 Jun; 48(3):847-9. PubMed ID: 3997251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary murine Chlamydia trachomatis pneumonia in B-cell-deficient mice.
    Williams DM; Grubbs B; Schachter J
    Infect Immun; 1987 Oct; 55(10):2387-90. PubMed ID: 3498690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.
    Pal S; Davis HL; Peterson EM; de la Maza LM
    Infect Immun; 2002 Sep; 70(9):4812-7. PubMed ID: 12183524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.